Interestingly, without effects on NSC proliferation, IFN-γ elevated the superoxide dismutase 2 (SOD2) level in NSC culturing, which improved the therapeutic effects of NSCs in the ischemic stroke model [117]. The gene discussed is SOD2; the disease is ischemic stroke.